Associates Domain - Net Worth and Insider Trading

Associates Domain Net Worth

The estimated net worth of Associates Domain is at least $221,489 dollars as of 2024-12-26. Associates Domain is the 10% Owner of Achillion Pharmaceuticals Inc and owns about 25,000 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $169,000. Associates Domain is the 10% Owner of Aldeyra Therapeutics Inc and owns about 10,358 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $51,997. Associates Domain is also the 10% Owner of Clovis Oncology Inc and owns about 32,758 shares of Clovis Oncology Inc (CLVSQ) stock worth over $491. Details can be seen in Associates Domain's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Associates Domain has not made any transactions after 2014-05-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Associates Domain

Associates Domain Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Associates Domain owns 18 companies in total, including Bionano Genomics Inc (BNGO) , Ocera Therapeutics Inc (OCRX) , and Regado Biosciences Inc (RGDO) among others .

Click here to see the complete history of Associates Domain’s form 4 insider trades.

Insider Ownership Summary of Associates Domain

Ticker	Comapny	Transaction Date	Type of Owner
BNGO	Bionano Genomics Inc	2018-08-21	10 percent owner
OCRX	Ocera Therapeutics Inc	2017-12-11	10 percent owner
RGDO	Regado Biosciences Inc	2016-11-01	10 percent owner
		2016-03-02	10 percent owner
		2015-06-24	10 percent owner
		2015-05-06	10 percent owner
		2014-11-19	10 percent owner
		2014-07-31	10 percent owner
		2014-05-01	10 percent owner
		2013-09-24	10 percent owner
		2013-06-25	10 percent owner
		2013-01-14	10 percent owner
		2011-11-15	10 percent owner
		2010-11-22	10 percent owner
		2010-10-06	10 percent owner
		2007-11-27	10 percent owner
		2006-05-09	10 percent owner
		2004-05-12	10 percent owner

Associates Domain Latest Holdings Summary

Associates Domain currently owns a total of 3 stocks. Among these stocks, Associates Domain owns 25,000 shares of Achillion Pharmaceuticals Inc (ACHN) as of October 6, 2010, with a value of $169,000 and a weighting of 76.3%. Associates Domain owns 10,358 shares of Aldeyra Therapeutics Inc (ALDX) as of May 1, 2014, with a value of $51,997 and a weighting of 23.48%. Associates Domain also owns 32,758 shares of Clovis Oncology Inc (CLVSQ) as of November 15, 2011, with a value of $491 and a weighting of 0.22%.

Latest Holdings of Associates Domain

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ACHN	Achillion Pharmaceuticals Inc	2010-10-06	25,000	6.76	169,000
ALDX	Aldeyra Therapeutics Inc	2014-05-01	10,358	5.02	51,997
CLVSQ	Clovis Oncology Inc	2011-11-15	32,758	0.02	491

Holding Weightings of Associates Domain

Associates Domain Form 4 Trading Tracker

According to the SEC Form 4 filings, Associates Domain has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the sale of 0 shares on October 6, 2010, which brought Associates Domain around $0.

According to the SEC Form 4 filings, Associates Domain has made a total of 0 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years. The most-recent trade in Aldeyra Therapeutics Inc is the sale of 0 shares on May 1, 2014, which brought Associates Domain around $0.

According to the SEC Form 4 filings, Associates Domain has made a total of 0 transactions in Clovis Oncology Inc (CLVSQ) over the past 5 years. The most-recent trade in Clovis Oncology Inc is the sale of 0 shares on November 15, 2011, which brought Associates Domain around $0.

Insider Trading History of Associates Domain

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Associates Domain Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Associates Domain Ownership Network

Ownership Network List of Associates Domain

No Data

Ownership Network Relation of Associates Domain

Associates Domain Owned Company Details

What does Bionano Genomics Inc do?

Who are the key executives at Bionano Genomics Inc?

Associates Domain is the 10 percent owner of Bionano Genomics Inc. Other key executives at Bionano Genomics Inc include Chief Financial Officer Gulsen Kama , director & President and CEO R. Erik Holmlin , and Chief Financial Officer Christopher P. Stewart .

Bionano Genomics Inc (BNGO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Bionano Genomics Inc (BNGO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bionano Genomics Inc (BNGO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Bionano Genomics Inc (BNGO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bionano Genomics Inc Insider Transactions

No Available Data

What does Ocera Therapeutics Inc do?

Who are the key executives at Ocera Therapeutics Inc?

Associates Domain is the 10 percent owner of Ocera Therapeutics Inc. Other key executives at Ocera Therapeutics Inc include 10 percent owner Brian H Dovey , 10 percent owner Domain Partners Viii, L.p. , and 10 percent owner Dp Viii Associates, L.p. .

Ocera Therapeutics Inc (OCRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ocera Therapeutics Inc Insider Transactions

No Available Data

What does Regado Biosciences Inc do?

Who are the key executives at Regado Biosciences Inc?

Associates Domain is the 10 percent owner of Regado Biosciences Inc. Other key executives at Regado Biosciences Inc include 10 percent owner Domain Partners Vi, L.p. , Chief Medical Officer Eric Lefebvre , and Chief Financial Officer Christopher Peetz .

Regado Biosciences Inc (RGDO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Regado Biosciences Inc (RGDO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regado Biosciences Inc (RGDO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Regado Biosciences Inc (RGDO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regado Biosciences Inc Insider Transactions

No Available Data

What does Syndax Pharmaceuticals Inc do?

Who are the key executives at Syndax Pharmaceuticals Inc?

Associates Domain is the 10 percent owner of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include Chief Financial Officer Keith A. Goldan , director & Chief Executive Officer Briggs Morrison , and President & Head of R&D Neil Gallagher .

Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary

Over the past 18 months, Associates Domain made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 105,710 shares made by Briggs Morrison , a net sale of 83,000 shares made by William Meury , and a net purchase of 1,250 shares made by Keith A. Goldan .

In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 188,710 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 1,250 shares were bought by its insiders, resulting in a net sale of 187,460 shares.

Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Syndax Pharmaceuticals Inc Insider Transactions

No Available Data

What does Glaukos Corp do?

Who are the key executives at Glaukos Corp?

Associates Domain is the 10 percent owner of Glaukos Corp. Other key executives at Glaukos Corp include CFO & SVP Corporate Development Joseph E Gilliam , SVP & Chief Financial Officer Alex R. Thurman , and director & 10 percent owner & Chief Executive Officer Thomas William Burns .

Glaukos Corp (GKOS) Insider Trades Summary

Over the past 18 months, Associates Domain made no insider transaction in Glaukos Corp (GKOS). Other recent insider transactions involving Glaukos Corp (GKOS) include a net sale of 314,757 shares made by Joseph E Gilliam , a net sale of 471,810 shares made by Thomas William Burns , and a net sale of 6,762 shares made by Alex R. Thurman .

In summary, during the past 3 months, insiders sold 17,603 shares of Glaukos Corp (GKOS) in total and bought 0 shares, with a net sale of 17,603 shares. During the past 18 months, 909,236 shares of Glaukos Corp (GKOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 909,236 shares.

Glaukos Corp (GKOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Glaukos Corp Insider Transactions

No Available Data

What does aTyr Pharma Inc do?

Who are the key executives at aTyr Pharma Inc?

Associates Domain is the 10 percent owner of aTyr Pharma Inc. Other key executives at aTyr Pharma Inc include Chief Financial Officer Jill Marie Broadfoot , Chief Medical Officer Sanjay Shukla , and See Remarks Nancy Krueger .

aTyr Pharma Inc (ATYR) Insider Trades Summary

Over the past 18 months, Associates Domain made no insider transaction in aTyr Pharma Inc (ATYR). Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 65,000 shares made by Sanjay Shukla , a net purchase of 3,410 shares made by Jill Marie Broadfoot , and a net purchase of 100,000 shares made by Paul Schimmel .

In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,590 shares of aTyr Pharma Inc (ATYR) were sold and 225,000 shares were bought by its insiders, resulting in a net purchase of 223,410 shares.

aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.

aTyr Pharma Inc Insider Transactions

No Available Data

What does Evofem Biosciences Inc do?

Who are the key executives at Evofem Biosciences Inc?

Associates Domain is the 10 percent owner of Evofem Biosciences Inc. Other key executives at Evofem Biosciences Inc include Chief Financial Officer Yan Zhang , director & 10 percent owner Kim P. Kamdar , and Chief Commercial Officer Atkinson Katherine Cocca .

Evofem Biosciences Inc (EVFM) Insider Trades Summary

Over the past 18 months, Associates Domain made no insider transaction in Evofem Biosciences Inc (EVFM). Other recent insider transactions involving Evofem Biosciences Inc (EVFM) include a net sale of 104 shares made by Yan Zhang , and a net sale of 10 shares made by Kim P. Kamdar .

In summary, during the past 3 months, insiders sold 0 shares of Evofem Biosciences Inc (EVFM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114 shares of Evofem Biosciences Inc (EVFM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 114 shares.

Evofem Biosciences Inc (EVFM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Evofem Biosciences Inc Insider Transactions

No Available Data

What does Marinus Pharmaceuticals Inc do?

Who are the key executives at Marinus Pharmaceuticals Inc?

Associates Domain is the 10 percent owner of Marinus Pharmaceuticals Inc. Other key executives at Marinus Pharmaceuticals Inc include Chief Commercial Officer Christina Shafer , CFO Steven Pfanstiel , and Chief Medical Officer Joseph Hulihan .

Marinus Pharmaceuticals Inc (MRNS) Insider Trades Summary

Over the past 18 months, Associates Domain made no insider transaction in Marinus Pharmaceuticals Inc (MRNS). Other recent insider transactions involving Marinus Pharmaceuticals Inc (MRNS) include a net sale of 18,588 shares made by Scott Braunstein , a net sale of 7,730 shares made by Joseph Hulihan , and a net sale of 7,461 shares made by Steven Pfanstiel .

In summary, during the past 3 months, insiders sold 0 shares of Marinus Pharmaceuticals Inc (MRNS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,796 shares of Marinus Pharmaceuticals Inc (MRNS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 45,796 shares.

Marinus Pharmaceuticals Inc (MRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Marinus Pharmaceuticals Inc Insider Transactions

No Available Data

What does Aldeyra Therapeutics Inc do?

Who are the key executives at Aldeyra Therapeutics Inc?

Associates Domain is the 10 percent owner of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include Chief Development Officer Stephen Machatha , See Remarks Bruce Greenberg , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .

Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary

Over the past 18 months, Associates Domain made no insider transaction in Aldeyra Therapeutics Inc (ALDX). Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 2,074,234 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 57,346 shares made by Stephen Machatha , and a net sale of 37,236 shares made by Bruce Greenberg .

In summary, during the past 3 months, insiders sold 0 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,034,319 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,352,054 shares.

Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aldeyra Therapeutics Inc Insider Transactions

No Available Data

What does Evoke Pharma Inc do?

Who are the key executives at Evoke Pharma Inc?

Associates Domain is the 10 percent owner of Evoke Pharma Inc. Other key executives at Evoke Pharma Inc include director & President and CEO David A Gonyer , Exec VP & Chief Bus. Officer Matthew J D'onofrio , and 10 percent owner Lvp Gp Iii, Llc .

Evoke Pharma Inc (EVOK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Evoke Pharma Inc (EVOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Evoke Pharma Inc (EVOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Evoke Pharma Inc (EVOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Evoke Pharma Inc Insider Transactions

No Available Data

What does Esperion Therapeutics Inc do?

Who are the key executives at Esperion Therapeutics Inc?

Associates Domain is the 10 percent owner of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Financial Officer Benjamin Halladay , Chief Operating Officer Sheldon L. Koenig , and Chief Commercial Officer Eric Warren .

Esperion Therapeutics Inc (ESPR) Insider Trades Summary

Over the past 18 months, Associates Domain made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 9,288 shares made by Eric Warren , a net sale of 26,997 shares made by Sheldon L. Koenig , and a net sale of 4,202 shares made by Joanne M. Foody .

In summary, during the past 3 months, insiders sold 18,230 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 18,230 shares. During the past 18 months, 43,732 shares of Esperion Therapeutics Inc (ESPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 43,732 shares.

Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Esperion Therapeutics Inc Insider Transactions

No Available Data

What does Celator Pharmaceuticals Inc do?

Who are the key executives at Celator Pharmaceuticals Inc?

Associates Domain is the 10 percent owner of Celator Pharmaceuticals Inc. Other key executives at Celator Pharmaceuticals Inc include other: Member of a 10% Group Eric W Roberts , other: See Remarks Section Cdk Associates, L.l.c. , and VP and Chief Financial Officer Fred M Powell .

Celator Pharmaceuticals Inc (CPXX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Celator Pharmaceuticals Inc (CPXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Celator Pharmaceuticals Inc (CPXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Celator Pharmaceuticals Inc (CPXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Celator Pharmaceuticals Inc Insider Transactions

No Available Data

What does Clovis Oncology Inc do?

Who are the key executives at Clovis Oncology Inc?

Associates Domain is the 10 percent owner of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Gillian C Ivers-read , and See remarks Lindsey Rolfe .

Clovis Oncology Inc (CLVSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Clovis Oncology Inc Insider Transactions

No Available Data

What does Zogenix Inc do?

Who are the key executives at Zogenix Inc?

Associates Domain is the 10 percent owner of Zogenix Inc. Other key executives at Zogenix Inc include EVP & CHIEF COMMERCIAL OFFICER Ashish M Sagrolikar , EVP/Chief Development Officer Gail M Farfel , and director & President and CEO Stephen J Farr .

Zogenix Inc (ZGNX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zogenix Inc (ZGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zogenix Inc (ZGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zogenix Inc (ZGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zogenix Inc Insider Transactions

No Available Data

What does Achillion Pharmaceuticals Inc do?

Who are the key executives at Achillion Pharmaceuticals Inc?

Associates Domain is the 10 percent owner of Achillion Pharmaceuticals Inc. Other key executives at Achillion Pharmaceuticals Inc include EVP & Chief Commercial Officer Paul E Firuta , EVP & Chief Medical Officer Steven Zelenkofske , and General Counsel Martha E Manning .

Achillion Pharmaceuticals Inc (ACHN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Achillion Pharmaceuticals Inc (ACHN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achillion Pharmaceuticals Inc (ACHN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achillion Pharmaceuticals Inc (ACHN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Achillion Pharmaceuticals Inc Insider Transactions

No Available Data

What does Orexigen Therapeutics Inc do?

Who are the key executives at Orexigen Therapeutics Inc?

Associates Domain is the 10 percent owner of Orexigen Therapeutics Inc. Other key executives at Orexigen Therapeutics Inc include 10 percent owner Baupost Group Gp, L.l.c. , 10 percent owner Baupost Group Llc/ma , and 10 percent owner Seth A Klarman .

Orexigen Therapeutics Inc (OREXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Orexigen Therapeutics Inc (OREXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orexigen Therapeutics Inc (OREXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Orexigen Therapeutics Inc (OREXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Orexigen Therapeutics Inc Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Associates Domain is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Associates Domain made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 48,967 shares made by Evan Loh , a net sale of 34,526 shares made by William M. Haskel , and a net sale of 31,250 shares made by Michael Bigham .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does NuVasive Inc do?

Who are the key executives at NuVasive Inc?

Associates Domain is the 10 percent owner of NuVasive Inc. Other key executives at NuVasive Inc include SVP & People and Culture Michael Farrington , Chief Accounting Officer Marc W. Rosenbaum , and director & Chief Executive Officer James Christopher Barry .

NuVasive Inc (NUVA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NuVasive Inc (NUVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NuVasive Inc (NUVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NuVasive Inc (NUVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

NuVasive Inc Insider Transactions

No Available Data

Associates Domain Mailing Address

Above is the net worth, insider trading, and ownership report for Associates Domain. You might contact Associates Domain via mailing address: One Palmer Square, Princeton Nj 08542.

Discussions on Associates Domain

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.